BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001040508 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 14, 2022

Total Value: $8.362B (100.0% shares, 0.0% debt)

Holdings (5)

— DIVERSEY HLDGS LTD 37.7%

Value $3.149B Shares 236,561,159 Share Price $13.31 Est. Cost/Share — Unrealized @ Report Date —

SGRY SURGERY PARTNERS INC 31.3%

Value $2.621B Shares 49,064,576 Share Price $53.41 Est. Cost/Share — Unrealized @ Report Date —

— CEREVEL THERAPEUTICS HLDNG I 23.5%

Value $1.966B Shares 60,632,356 Share Price $32.42 Est. Cost/Share — Unrealized @ Report Date —

AVAH AVEANNA HEALTHCARE HLDGS INC 7.2%

Value $604M Shares 81,600,880 Share Price $7.40 Est. Cost/Share — Unrealized @ Report Date —

ADV ADVANTAGE SOLUTIONS INC 0.3%

Value $23.18M Shares 2,890,000 Share Price $8.02 Est. Cost/Share — Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
—	DIVERSEY HLDGS LTD	236,561,159	$3.149B	37.7%	$13.31	—	—	ORD SHS	G28923103
SGRY	SURGERY PARTNERS INC	49,064,576	$2.621B	31.3%	$53.41	—	—	COM	86881A100
—	CEREVEL THERAPEUTICS HLDNG I	60,632,356	$1.966B	23.5%	$32.42	—	—	COM	15678U128
AVAH	AVEANNA HEALTHCARE HLDGS INC	81,600,880	$604M	7.2%	$7.40	—	—	COM	05356F105
ADV	ADVANTAGE SOLUTIONS INC	2,890,000	$23.18M	0.3%	$8.02	—	—	COM CL A	00791N102